CompanyOverview|NYSE:HIMS] One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made ...

Interestingly, weight loss is a known side effect of this medication, and that’s what has sparked interest beyond the ...

Ozempic copycats could come with hefty price tags as FDA declares end of semaglutide shortage Former first lady of the United ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

While weight loss medications can deliver significant results, our bodies eventually adapt to everything. And many people end ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

An analysis of differential coding patterns between Medicare Advantage (MA) and Traditional Medicare (TM) plans estimated how much coding differs between insurers and how much extra revenue insurers ...

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) ...

Experts across healthcare debunk 15 common myths about GLP-1 medications—covering everything from access and cost to ...